United States

Showing 131-140 of 333 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Development of simulation tools to support adaptation of automated insulin delivery algorithms across pregnancies complicated by type 1 diabetes	Rector & Visitors of the University of Virginia	Jacopo Pavan	Improving Lives	01-March-2025 to 28-February-2027	$189,316.00
Leveraging Real-Time Insulin Sensitivity Estimation for the Adaptation of a Fully-Closed Loop Automated Insulin Delivery System to Improve Glycemic Control in Adolescents with Type 1 Diabetes	Rector & Visitors of the University of Virginia	H. Marcela Moscoso Vasquez	Improving Lives	01-April-2024 to 31-March-2026	$189,709.00
Clinical Validation of a Smart Bolus Calculator Informed by Insulin Sensitivity in Adults and Adolescents with Type 1 Diabetes	Rector & Visitors of the University of Virginia	Chiara Fabris	Improving Lives	01-June-2020 to 31-December-2025	$604,390.26
Pancreatic Islet Transplantation for the Treatment of Type 1 Diabetes: In-Silico Developments to Support Clinical Advancements	Rector & Visitors of the University of Virginia	Chiara Fabris	Cures	01-January-2025 to 31-December-2025	$299,916.19
Electrochemiluminescence-based islet autoantibody assays detect the islet autoimmunity earlier and more disease specific than radio-binding assay in the longitudinally followed new-born cohort of TEDDY study	Regents of the University of Colorado	Xiaofan Jia	Cures	01-June-2025 to 31-May-2027	$499,989.00
Newly identified novel autoantibodies specific to β-cell surface ZnT8 antigen as an early biomarker in type 1 diabetes	Regents of the University of Colorado	Xiaofan Jia	Cures	01-September-2023 to 28-February-2026	$499,998.96
Relationship of Time-In-Range with microvascular complications in type 1 diabetes	Regents of the University of Colorado	Viral Shah	Improving Lives	01-August-2021 to 31-July-2024	$133,632.77
Testing the role of the PI3K-AKT-FOXO1-CXCR4 pathway in the bone marrow selection of anti-insulin B cells in T1D	Regents of the University of Colorado	Roberta Pelanda	Cures	01-November-2023 to 31-October-2026	$826,284.00
Targeting sub-micron ultrasound contrast agents to the immune-infiltrated islet microenvironment in Type1 diabetes	Regents of the University of Colorado	Richard Benninger	Cures	01-July-2024 to 30-June-2027	$900,000.00
Defining human T cell-myeloid cell interactions in the islets	Regents of the University of Colorado	Rachel Friedman	Cures	01-March-2023 to 28-February-2026	$110,000.00